Liu SW - Search Results

1

MiR-138: A promising therapeutic target for cancer.

Sha HH, Wang DD, Chen D, Liu SW, Wang Z, Yan DL, Dong SC, Feng JF. Sha HH, et al. Among authors: liu sw. Tumour Biol. 2017 Apr;39(4):1010428317697575. doi: 10.1177/1010428317697575. Tumour Biol. 2017. PMID: 28378633 Free article. Review.

2

Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis.

Liu Y, Yu S, Liu S, Cao H, Ma R, Wu J, Feng J. Liu Y, et al. Sci Rep. 2015 May 21;5:10516. doi: 10.1038/srep10516. Sci Rep. 2015. PMID: 25994814 Free PMC article.

3

[Analysis of C.3925_3929 deletional mutations of APC gene in pedigrees with familial adenomatous polyposis].

Chen Q, Liu S, Feng J, Zhang X, Chen S, Ma G, Zhu M, Zhang Y, Yu J. Chen Q, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):524-8. doi: 10.3760/cma.j.issn.1003-9406.2015.04.017. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26252100 Chinese.

4

LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.

Wu Y, Yu DD, Hu Y, Cao HX, Yu SR, Liu SW, Feng JF. Wu Y, et al. Among authors: liu sw. Biochem Biophys Res Commun. 2015 Nov 27;467(4):900-5. doi: 10.1016/j.bbrc.2015.10.047. Epub 2015 Oct 21. Biochem Biophys Res Commun. 2015. PMID: 26471306

5

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.

Sha HH, Wang DD, Yan DL, Hu Y, Yang SJ, Liu SW, Feng JF. Sha HH, et al. Among authors: liu sw. Biosci Rep. 2017 Jan 27;37(1):BSR20160332. doi: 10.1042/BSR20160332. Print 2017 Feb 28. Biosci Rep. 2017. PMID: 28053197 Free PMC article. Review.

6

Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment.

Cao H, Yu S, Chen D, Jing C, Wang Z, Ma R, Liu S, Ni J, Feng J, Wu J. Cao H, et al. FEBS Open Bio. 2016 Dec 20;7(1):35-43. doi: 10.1002/2211-5463.12147. eCollection 2017 Jan. FEBS Open Bio. 2016. PMID: 28097086 Free PMC article.

7

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer.

Zang J, Hu Y, Xu X, Ni J, Yan D, Liu S, He J, Xue J, Wu J, Feng J. Zang J, et al. Onco Targets Ther. 2017 Jan 18;10:409-415. doi: 10.2147/OTT.S124124. eCollection 2017. Onco Targets Ther. 2017. PMID: 28176920 Free PMC article.

8

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.

Hu Y, Zang J, Cao H, Wu Y, Yan D, Qin X, Zhou L, Fan F, Ni J, Xu X, Sha H, Liu S, Yu S, Wang Z, Ma R, Wu J, Feng J. Hu Y, et al. Oncotarget. 2017 Feb 28;8(9):15802-15814. doi: 10.18632/oncotarget.15007. Oncotarget. 2017. PMID: 28178657 Free PMC article.

9

Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.

Hu Y, Qin X, Yan D, Cao H, Zhou L, Fan F, Zang J, Ni J, Xu X, Sha H, Liu S, Yu S, Wu J, Ma R, Feng J. Hu Y, et al. Tumour Biol. 2017 Mar;39(3):1010428317691659. doi: 10.1177/1010428317691659. Tumour Biol. 2017. PMID: 28345454 Free article.

10

Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.

Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J. Qin X, et al. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28553110 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

669 results

Search Page